EAPC Premium Access

Evaluation of LDL cholesterol level in patients with coronary artery disese after cardiac rehabilitation

Congress Session

About the speaker

Doctor Najat Mouine

Military Hospital Mohammed V, Rabat (Morocco)
2 presentations
0 follower

9 more presentations in this session

Lipids - Poster discussant:

Thumbnail

Improvement of lipid profile post cardiac rehabilitation according to the patient's level of risk in a tertiary hospital

Speaker: Doctor A. Chauca Tapia (Girona, ES)

Thumbnail

Efficacy of the PCSK9 inhibitors evolocumab/alirozumab in the reduction of LDL and Lp (a) in patients with familial hypercholesterolemia/manifest atherosclerosis in a real world setting

Speaker: Mr M. Poudel (Bielefeld, DE)

Thumbnail

Anti-PCSK9 in everyday clinical practice

Speaker: Doctor R. Cadenas Chamorro (Madrid, ES)

Thumbnail

Safety aspects and side effects of the novel lipid-lowering PCSK9 inhibitors evolocumab /alirozumab in atherosclerotic patients with familial hypercholesterolemia under lipid apheresis

Speaker: Mr M. Poudel (Bielefeld, DE)

Thumbnail

Access the full session

Poster Session 1 - Lipids

Speakers: Doctor N. Mouine, Doctor A. Chauca Tapia, Mr M. Poudel, Doctor R. Cadenas Chamorro, Mr M. Poudel
Thumbnail

About the event

Image

EuroPrevent 2018

19 April - 21 April 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk